GLP-1 drugs , or glucagon-like peptide-1 analogs , represent a substantial development in how we approach type 2 diabetes . These prescription therapies work by mimicking the body’s inherent GLP-1 https://minibookmarks.com/story21693091/glp-1-a-major-breakthrough-in-blood-sugar-management